Company Description
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.
Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology.
The company offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; Collage, a combinant human Collagen type I solution; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound care product for the treatment of deep surgical incisions and deep wounds.
It also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product.
The company has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization.
The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019.
CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
| Country | Israel |
| Founded | 2004 |
| Employees | 39 |
| CEO | Eran Rotem |
Contact Details
Address: Weizmann Science Park, 4 Oppenheimer Rehovot, 7670104 Israel | |
| Phone | 972 73 232 5600 |
| Website | collplant.com |
Stock Details
| Ticker Symbol | OPHI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1631487 |
Key Executives
| Name | Position |
|---|---|
| Christopher E. Galvin | Chairman, Chief Executive Officer and Pres |
| David Querciagrossa CPA | Chief Financial Officer |
| John C. Galvin | Executive Vice President of Sales |
| Tapan Chatterjee | Senior Vice President of Research & Development |
| William G. Styles | President of Lawn and Garden Division and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 12, 2026 | 6-K | Report of foreign issuer |
| Nov 12, 2026 | 6-K | Report of foreign issuer |
| Nov 5, 2026 | 6-K | Report of foreign issuer |
| Nov 4, 2026 | 6-K | Report of foreign issuer |
| Nov 3, 2026 | 6-K | Report of foreign issuer |
| Nov 2, 2026 | 6-K | Report of foreign issuer |
| Oct 29, 2026 | 6-K | Report of foreign issuer |
| Oct 27, 2026 | 144 | Filing |
| Oct 22, 2026 | D | Notice of Exempt Offering of Securities |
| Oct 15, 2026 | 6-K | Report of foreign issuer |